Abrezekimab
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Rα1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.
Product Specifications
CAS Number
2043952-59-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL516285V 500 µL Each
Rnf115 Mouse shRNA Lentiviral Particle (Locus ID 67845)
Sign In for Pricing
View Details 
bs-6925R-APC-Cy7 100 µL
CCDC51 Polyclonal Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details 144441-FITC 100 µL
DDT (D-dopachrome tautomerase, Phenylpyruvate tautomerase II) (FITC)
Sign In for Pricing
View Details